Thursday, November 30, 2006

'Secret' Google Display Advertising Network Rumored

'Secret' Google Display Advertising Network Rumored

Google has reportedly launched a "secret" CPM online ad network, dubbed the Google Display Advertising Network and being tested since Oct. 1.

With the invitation-only Google Display Advertising Network, Google is targeting Fortune 1000 companies, writes John Chow, saying he has been invited and has been participating in the display and video ad network. "Google has been hand-selecting sites…that they want to put in front of Fortune 1000 companies. The goal being to sell these big companies display and video ads at a very high CPM," he writes.

Publishers invited to join the display ad network negotiate a flat CPM rate with Google, the contracts are for one year, and the publishers have to guarantee a certain minimum amount of monthly inventory, according to Chow. "Publishers can serve more than the minimum amount and still receive the same CPM rate for the overage," he writes.

Google provides "extremely limited" reporting via weekly email, reporting only weekly ad impressions and pageviews, Chow writes, adding that he is "not allowed to reveal CPM or any financial data" regarding the  Google Display Advertising Network.

buzz this

Amanda Watlington recently wrote a review on different audio/video podcast publishing technologies. Below is an excerpt:

"With all of the heavy equipment (your phone) in hand, here is what you will need to do to prepare the audio. Sign up for a podcatching service such as Hipcast (http://www.hipcast.com), AudBlog (http://www.audblog.com), Gcast (http://www.gcast.com) or Gabcast (http://www.gabcast.com). Be sure to read carefully what each service offers. My personal preference is Hipcast, because it lets me choose how I want to handle the final audio file. I can select which of my blogs/web pages that it will post to, and I can even rework the audio file if I want to -- but that is more advanced than a beginner needs."

I personally tried Hipcast, following Amanda's recommendation, and did indeed find it extremely easy to create and post -- however, I am strill trying to understand how to tie the audio file to a spefic story for "color commentary".

Source: Join the Podcast Revolution with Your Phone
http://www.wilsonweb.com/newmedia/watlington-podcast-phone.htm

by Amanda Watlington, Ph.D., A.P.R. Searching for Profit Charleston, MA

buzz this

Wednesday, November 29, 2006

Educating On Erectile Dysfunction In Hong Kong

Educating On Erectile Dysfunction In Hong Kong

source: Marketing Vox

Today, the Wall Street Journal
reported on an interesting marketing campaign implemented by Bayer in Hong Kong for its anti-impotence medication Levitra. Bayer faced two obstacles to driving uptake of its medication in this market:

1.    Direct-to-consumer advertising is not allowed in Hong Kong

2.    Men are unwilling to discuss this issue with their doctors or acknowledge they have it.  

To overcome these obstacles, Bayer’s public relations agency,
Golin Harris, created an advertising campaign that made light of the problem without mentioning the brand name.  According to the Journal:

“Part of the humor is that the ads leave embarrassing words and ideas up to innuendo and pun. Instead of mentioning erectile dysfunction specifically, most of them simply feature a photo of a limp, hot-dog-shaped balloon. One features a satisfied customer wearing a Superman costume with the ‘S’ on his chest replaced by the Chinese word for ‘upright.’ That character also happens to be the first in Levitra's Chinese name.”

The campaign has been a great success.  Sales of Levitra have increased by 244% and Bayer spent $190,000 on the campaign.  To view an advertisement, please see the image below.

http://www.healthcarevox.com/NA-AL206_ADVERT_20061122185855-thumb.jpg

 
buzz this

Tuesday, November 28, 2006

Merck to cut back on DTC TV ads, says No. 2 exec 11-28-06

Merck to cut back on DTC TV ads, says No. 2 exec  11-28-06

Merck plans to scale back its DTC television advertising for new drugs in favor of a more targeted, Internet-focused approach, the company's No. 2 executive told The Financial Times this week.

Merck's president of global human health, Peter Loescher, said in an interview with The Times that changes in viewer habits and awareness of a more cost-effective use of resources have made a new approach necessary.

"The new model will also move away from a broad broadcast DTC approach in its classical sense. It has to. Because as a consumer we’re sitting in front of our TV and we’re switching all the time," he said.
Loescher said Merck is experimenting with different channels of marketing, including Web sites such as iVillage, a woman's site and in online communities, to better know its target audiences and how its marketing messages work.

"We tried to target specific populations—be far more targeted and far more diverse," he said.
A call to a Merck spokesman seeking further details went unreturned at press time.

Merck CEO Dick Clark appointed Loescher as his top lieutenant in May to restructure the company's sales and marketing approach and oversee public affairs.

Loescher is slated to make his debut to investors during a company presentation Dec. 12.

buzz this

Monday, November 27, 2006

Novartis-sponsored Web site features actor, free downloads

Novartis-sponsored Web site features actor, free downloads
 
 

Novartis is sponsoring a Web site and educational program about sickle cell disease featuring African American actor Larenz Tate. The site, www.AskLarenzAboutIron.com, is designed to raise awareness about iron overload, a possible side effect from frequent blood transfusions for sickle cell disease. The disease affects about one in 500 African Americans, and iron overload is an under-recognized complication of transfusions. In addition to tools and information about iron overload, www.AskLarenzAboutIron.com also includes "fun" features, such as downloadable computer wallpaper and an autographed picture of Tate. The site links to www.AskAboutIron.com, another Novartis-sponsored site, where users can sign up for free information from the company. Novartis makes the iron overload treatment Exjade.

buzz this

Boomers' caregiving role increasing, affecting personal lives

Boomers' caregiving role increasing, affecting personal lives
 
 

An increasing number of Americans are caregivers, and providing this care impacts many aspects of their lives, according to a survey from John Hancock Life Insurance Company. The survey found that 69% of respondents said providing care or financial assistance has significantly affected their personal lives, and 62% said it has a significant impact on their family. Also, 45% said that caregiving significantly affects their work. Caregiving is also more common among baby boomers, which have been called the "sandwich generation" because they care for both their children and aging parents.  According to new Manhattan Research data, nearly 60% of caregivers search online for health information, making the Internet a critical channel for reaching them.

buzz this

HEME MALIGNANCIES

HEME MALIGNANCIES, by Physicians Education Resource.
 
This Web site is supported by unrestricted educational grants from Genentech BioOncology/ Biogen Idec and Bristol-Myers Squibb.

http://www.hememalignancies.com/

buzz this

Friday, November 24, 2006

Pew: Podcast Audience Doubles

Pew: Podcast Audience Doubles
by Wendy Davis, Friday, Nov 24, 2006 6:00 AM ET
ABOUT TWICE AS MANY WEB users are downloading podcasts now compared to six months ago, according to new data from the Pew Internet & American Life Project.

Twelve percent of Web users surveyed in August said they have downloaded a podcast--up from 7% who said the same in a survey conducted between February and April. Those numbers appear higher than what was reported in July by media measurement company Nielsen//NetRatings, which found that 6.6% of U.S. adult Web users had downloaded a podcast in the last 30 days.

Pew attributed the increase to the surge in MP3 ownership as well as the vast amount of content now available--more than 26,000 podcasts and 1 million episodes, according to the report.

Podcast downloaders are more likely to be male and connect via broadband, according to Pew. The study found that 15% of men downloaded podcasts, compared to just 8% of women. In addition, 14% of those with home broadband connections had transferred podcasts to their computers, compared to 10% of dial-up users.

Online tenure also correlated with podcast use; 13% of users with at least six years of online experience reported downloading podcasts, while just 6% of users with three years' or less experience online had done so.

Despite the increase in number of downloaders, the activity still appears to be an infrequent occurrence; only 1% of respondents said they downloaded a podcast on a typical day.

For the report, Pew conducted a telephone survey of 2,928 adults by phone.

buzz this

Tuesday, November 21, 2006

Breaking News: E-marketing Feature in this month's MED AD NEWS

E-marketing // Novemeber 2006, MED AD NEWS

Pharmaceutical companies providing resource-intensive Websites to their consumers were winners at the 2006 Webby Awards, held June 12, 2006. The InVision Guide to A Healthy Heart, found at invisionguide.com/heart, won in the health-care category. Healthy Heart is a site sponsored by Novartis (novartis.com) and designed by Anatomical Travelogue Inc. (anatomicaltravel.com) with information about heart function, disease, and treatment. Change of HAART, found at changeofhaart.com, won in the pharmaceutical category. Change of HAART, sponsored by Gilead Sciences Inc. (gilead.com) and designed by Ignite Health (ignitehealth.com), is focused on past and present HIV treatment and the importance of adherence to treatment.

The Webby Awards are presented annually by the International Academy of Digital Arts and Sciences, a 550-member body of Web experts, business figures, and creative celebrities. The awards honor excellence on the Internet and include Websites, interactive advertising, and online film and video.

"Pharmaceutical companies have been successful on the Web because there is a very high demand from general consumers to find out more information about pharmaceuticals and about their health," says David Michel Davies, executive director, the Webby Awards (webbyawards.com). "This is an industry where the knowledge was highly centralized, at the doctor’s office, for a very long time. But now the Web has given individuals the opportunity to research and find out more information about whatever health condition they’re interested in. The pharmaceutical companies that have recognized that and realized that it’s not just about pushing a specific product or a condition, but about creating a resource for those people to go to, are the ones that have been the most successful on the Web."

Mr. Davies is particularly impressed by Gilead’s Change of HAART site. "Change of HAART did something striking," he says. "Highly active retroviral therapy is a very complex issue that people generally don’t know a lot about. It can be frightening, especially if you are somebody who potentially has HIV. Change of HAART succeeds because they give the site a warm feeling and make it easy for a user to feel comfortable, to read the literature, and to interact with it. Everything from the videos to the handwritten text to even the use of the acronym H-A-A-R-T makes the site warm and inviting and helps to take away some of the scary, austere feeling that someone going there might have. That is a quality that is very important for health and pharmaceutical sites."

According to Mr. Davies, providing resource-intensive Websites can be a successful strategy for pharmaceutical companies. Most individuals using the Internet as a health-care resource begin by searching for general information about conditions rather than specifics about particular drugs. Websites that are resource-intensive, with useful research content and links to additional information, will appear higher in a typical individual’s search rankings.

Mr. Davies has another suggestion for pharmaceutical companies. He believes that sites should offer individuals the opportunity to share their experiences with their conditions and the sponsoring company’s products. One of the pharmaceutical nominees, Stand Strong, took this approach. Stand Strong can be found at standstrong.com. The site was designed by Moroch & Associates (moroch.com) and is sponsored by Mission Pharmacal Co. (missionpharmacal.com). The site consists of women sharing their stories about dealing with osteoporosis.

BannerMoments.com is another site that follows Mr. Davies’ suggestion. The site was designed and sponsored by Incendia Health Studios, an agency founded by Ignite Health, and focuses on breast cancer support and awareness (see related story on page 64).

BannerMoments.com allows visitors to develop personal Web banners that can be used to express individual messages about their fight against breast cancer. The site also provides links to a variety of breast cancer information resources and offers sponsorship opportunities for pharmaceutical marketers interested in reaching cancer patients and their extended families and friends. Incendia (incendiahealth.com) is focused on the field of chronic disease education.

"Marketers may fear this a little bit, because at some level it is creating opportunity for somebody to give negative feedback about your product on your site," Mr. Davies told Med Ad News. "But if there’s an issue, people are going to talk about it somewhere. And this sort of site can create a lot of good dialogue internally in a company. It’s a little bit more honest, and people inside the company can learn more about what their potential customers are saying. The customer is always a keystone of innovation."

Being nominated for or winning a Webby can be a good way to drive traffic to a Website. Between 2 million and 3 million visits to nominated sites by participants in the Webby People’s Choice Awards were recorded in 2005, and the awards event itself received coverage from a variety of general, marketing, and ad agency media, including CNN, MSNBC, CNBC, the International Herald-Tribune, Ad Age, and Ad Week.

The Webby Awards also provide validation for the work that went into creating a Website. "One of the challenges of being in the creative industry is that it is hard to measure whether you did a good job," Mr. Davies says. "A real-estate agent can say, ‘I sold 15 houses this year, I did a great job.’ But for somebody who is creating breathtaking online experiences, their success is a matter of opinion. So the kind of validation that the Webby Awards brings can be great for your team."

The nominees for Webby awards are chosen from a pool of self-entered Websites and Internet content. Companies or agencies can enter their site in the competition via an online entry form found on the Webby Awards’ Website. The Webbys are presently accepting entrants for the 2007 Awards; the final deadline for entry into the 2007 competition is Dec. 15, 2006.

buzz this

Amgen Launches ChemoCoach.com and ``My Cancer Coach'' Contest

Amgen Launches ChemoCoach.com and ``My Cancer Coach'' Contest in Conjunction with Sponsorship of College Hoops Classic Benefiting Coaches vs. Cancer

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Nov 16, 2006 - Cancer survivors now have a unique opportunity to thank their cancer coach -- the spouse, family member or friend who played a crucial role in helping them through the battle -- through a contest sponsored by Amgen Oncology. Starting today, cancer patients can nominate their "cancer coach" at www.ChemoCoach.com  by completing and submitting a short essay.

Amgen Oncology is supporting the fight against cancer on multiple fronts including serving as a major sponsor of the College Hoops Classic benefiting Coaches vs. Cancer. The Classic kicks off the 2006-2007 college basketball season and teams Amgen Oncology with the National Association of Basketball Coaches (NABC) to raise funds for the American Cancer Society. The Coaches vs. Cancer program, created by the NABC and American Cancer Society, has raised more than $25 million to support cancer patients since its inception in 1993.

In conjunction with the sponsorship, Amgen Oncology also recruited Dick Vitale -- the voice of college basketball -- to help spread the word about the ChemoCoach(TM) program, a valuable and free resource for cancer patients and caregivers.

"Check out ChemoCoach.com if you're currently undergoing chemotherapy or helping a family member or friend through it," said Vitale. "And if a loved one played a huge role in supporting your fight with cancer, then nominate them for the My Cancer Coach contest. All cancer coaches are big time winners but two will receive a trip for two to New York City and tickets to the final round of next year's College Hoops Classic."

At www.ChemoCoach.com, visitors can also register to receive an educational email series, which is a free support program that delivers small doses of powerful information to help cancer patients and their caregivers better manage the chemotherapy journey. The site also acts as the gateway to additional resources and information.

"In addition to doctors and nurses, we know that a cancer coach can be a well-informed and active member of a cancer patient's support team," said Cynthia Schwalm, vice president and general manager of Amgen Oncology. "Through the ChemoCoach program we help patients and their friends and family members prepare for and manage side effects of chemotherapy, ask the right questions of their doctors and much more."

The championship round of this year's College Hoops Classic is taking place in New York City on November 16th and 17th. Additional information about the "My Cancer Coach" contest including an official entry form and a complete list of rules are available at www.ChemoCoach.com. The entry deadline is February 28, 2007.

buzz this

Thursday, November 16, 2006

FDA expands use of breast cancer drug

FDA expands use of breast cancer drug

Thu Nov 16, 7:22 PM ET

The breast cancer drug Herceptin received expanded federal approval Thursday to include treatment of some women after they have undergone surgery.

In two clinical trials, women given the drug along with chemotherapy had fewer relapses in the three years after surgery — either to remove a lump or the whole breast — than those just given standard chemotherapy, the Food and Drug Administration said in announcing the additional approval. The drug is made by Genentech Inc. of South San Francisco, Calif.

Herceptin is only for the estimated 20 percent of patients whose breast tumors churn out too much of a protein known as HER-2. About 50,000 women in the United States and 250,000 worldwide are diagnosed with this type, called HER-2 positive, each year.

In 1998, the FDA approved Herceptin to treat breast cancer after it had spread to other parts of the body. Thursday's approval expands its use to women with cancer in the breast or lymph nodes that has been surgically removed, the FDA said.

The most serious side effect of Herceptin is heart failure. Only patients with HER-2 positive tumors, and who do not have heart failure or a weak heart, should be given the drug, also known as trastuzumab.

___

On the Net:

Food and Drug Administration: http://www.fda.gov

Genentech Inc.: http://www.gene.com

 
buzz this

Monday, November 13, 2006

Web-Based Search Engines Help Diagnose Difficult Cases

Web-Based Search Engines Help Diagnose Difficult Cases

Reuters Health Information 2006. © 2006 Reuters Ltd.
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

NEW YORK (Reuters Health) Nov 10 - Using Google to conduct web-based searches on the internet can assist in the diagnosis of difficult cases, physicians in Australia report in BMJ Online First. In fact, the investigators believe that Google may be more effective than using PubMed.

"Useful information on even the rarest medical syndromes can now be found and digested within a matter of minutes," write Dr. Hangwi Tang and Jennifer Hwee Kwoon Ng.

According to the two clinicians, based at Princess Alexandra Hospital in Brisbane, physicians and patients are more frequently using the world wide web to find answers for health problems.

After witnessing a patient's father correctly diagnose his son's condition as "Paget-von Schrotter syndrome," the two clinicians analyzed in more detail how well Google is at leading doctors to the correct diagnosis.

They obtained 26 cases published in The New England Journal of Medicine during 2005. Without reading the differential diagnosis and conclusion of each case, they selected three to five search terms from each case. The researchers then did a Google search for each case using those terms, and selected the three diagnoses that seemed to fit the symptoms and signs.

It turns out they were correct 58% of the time.

For some of the other diagnoses, Google gave a correct diagnosis that was not specific enough for the physicians to consider it to be correct. For example, the Google diagnosis was "extrinsic allergic alveolitis," instead of the more specific "extrinsic allergic alveolitis caused by Mycobacterium avium."

The authors point out that their chances of success were increased by selecting "statistically improbable phrases" and scanning no more than five pages of the search result.

Drs. Tang and Ng believe that a web search will be more effective for conditions with unique symptoms and signs. Less success will be achieved with non-specific symptoms or common diseases with rare presentations.

Google has access to more than 3 billion articles, they note, and "has far exceeded PubMed as the search engine of choice for retrieving medical articles." It will be even more valuable when it releases a new version, Google Scholar, because it will include only peer-reviewed articles.

BMJ Online First 2006.

buzz this

From the AdTech Blog: Linking and Optimization for Better Rankings and More Traffic

Linking and Optimization for Better Rankings and More Traffic

An intense session on how search engines work. Mike Grehan, "Global Search Marketing Nomad," wrote the first book on SEM and started with a series of bad joke. Bad jokes aside, it was a great dissection of how things work.

The most frequent question Grehan is asked is, "Can you help me get into top 10 of major search engines?" Why should you be? The answer is difficult, but he tried to cover the major points of SEM. He covered a lot of ground in this session. Here's what he talked about (sort of like the notes I took in class).

1. The 4 Ps of Online Marketing
Positioning: Using paid and organic search to drive traffic
Permission: Opening a dialogue with potential new customers. CRM. Get an e-mail address.
Partnership: Affiliate marketing, co-promotion, sponsorship and joint venture.
Performance: Measuring the success of your web site and online marketing strategies.
2. The Search Marketing Mix
Ask yourself the following questions. Who are we? What do we do? What are we known for a? What's your message? Then list the top ten phrases which cover the content of your website. Each phrase (or search term) should be two words or more. Talk to people OUTSIDE the organization! Grehan once had a discussion with a bank client who said "we lend more money than anybody else in America", so "Lend money" should be the keywords. Wrong. The keywords should be "borrow money". Put yourself in the mind of the searcher. Talk to telemarketing people to get a handle on this.
3. Preparing a Campaign
Be sure you have a unique page of good quality content for each search term you want to be found under. Remember: Search engines return web pages - not websites! You need to optimize every page for search
4. How Search Engines Work
There are six ways search engines work:
Organic
Pay per click
Cost per click
Pay for consideration (like Yahoo, one of our editors will visit your site within 7 days)
Pay for inclusion (Yahoo, Inktomi)
Trusted feed (XML feed for e-commerce sites)

It's a good idea to use a norobots.txt file to exclude landing pages for campaigns, for example. Search engines will penalize you for duplicate content.

Getting to the top 4 listings is even more imperative. A lot of times with Google where there were 2 paid listings now there are 3, which push organic listings down "below the fold". According to a recent study consumer behavior. People would prefer to reformulate a query rather than scroll down.

Organic results are a bit like doing PR. Pay per click is like buying targeted classified ads.

Where do people look? Upper left side of search results pages dominate--and in fact, more than 70% of clicks take place in organic results.

How do search engines work? Andrew Broder was at Altavista and has formulated a "taxonomy of search":
Navigational: when a surfer really wants to reach a particular website. This goes directly to the website.
Informational: really looking for factual information on the web. Looking for specific info, very close to classical information retrieval. Like the purchase cycle: start with something ambiguous, then refine. User intent is key.
Transactional: the surfer wants to do something on the web, through the web. Shop, download files, find a service like yellow pages.

Grehan recommended that we stop obsessing over crawler activity. Crawlers follow links and collect text, period. They have only the tiniest influence over ranking (an off page factor). It's possible to rank at a search engine without ever having a page crawled.

Most search engines use a "vector space model": term frequency in the document, how many times does it appear on this page? When writing copy for web pages, be as focused as you can. Keyword position and proximity are key. Use:
Keywords in title
Keywords in headline
Keywords in body copy
Keywords in alt tags
Text links and/or link to site map

Remember, you're writing for a "man and a machine." The best analogy is to think that a search engine is like a blind person reading a newspaper: straight to the title, then the headline, then the body copy. Here are some more tips:
Metatags: Fine for controlled homogenous corpus/collection e.g. a digital library. Very poor for heterogeneous corpus/collection with no standard/control
Don't worry about Page Rank - He calls this "GAS - Google Anxiety Syndrome". Pagerank is green fairy dust.

Links. However, are important. Hyperlink analysis algorithms make these eassumptions
1. a hyperlink from a to b is a recommendation of b by a
2. if page a and b are connected by a link, they might be on the same topic
3. if c links to to two pages, a and be are co-cited and related
You need to get links from cyber communities--one great link from inside your community is worth a thousand lesser links. You have total control over who you link to . Reciprocal linking works.

Grehan concluded with his "10 essentials about linkage":
1. Remember, it's quality material which other content sites want to link to. When they link to you, their reputation goes with it. Content is king. Go to your website and write 10 reasons why people should link to your site. If you can only find, 5, you should rethink your website.
2. Search engines look at anchor text in links and text close to the links to give them a clue as to what the existing page is about, and also what the target page is about. "Click here" is the most used and abused anchor text. Don't just say "click here". Say "click here for everything you wanted to know about blue widgets". The target page should have these words as well. Go to Google and search for "click here." The #1 result is the Adobe Acrobat download page, yet click here doesn't appear on this page--everybody's links say "Click here to download Adobe Acrobat." Googling "miserable failure" will take you to George Bush's home page (which has no mention of "miserable failure"). Do it within reason.
3. Search Engines have already decided who they think is important. So use search engines to find linking partners. Use this syntax: link:www.apple.com. But it's better to use a keyword/phrase search. It's a good idea to look at your competitors this way.
4. Don't dilute your quality content by trying to spread it out over the whole site if it's not necessary. Create one good, comprehensive page that others will feel compelled to link to or which you can suggest as the most authoritative page on the subject matter to which to link.
5. A well-run affiliate program can bring you plenty of traffic and deliver plenty of sales. But an affiliate program could also cause havoc with your linking strategy. A redirected link via commission junction or clickbank can deplete the power of any direct links you may have already had
6. Do be choosy about who you link to and who links back to you.
7. Don't try and fake your linkage doata. Don't create spam islands ready to be blown out of the water. SEs can see if links grow too quickly and kill you.
8. How do you ask for a link? Provide a value proposition
9. The links business is very time consuming. Should I get someone else to do it? Maybe even buy a robot to do it. Weigh this carefully.
10. Unless you want to be a business directory don't waste time building a link directory--build your content and your business.

At the end of a whirlwind session, Grehan gave this last piece of advice. Keep track of your backlink data. Keep a spreadsheet of your rankings. If you drop down, check links. One of his clients dropped from a top position to somewhere in the low thousandth position. A link on a news site can break if the site changes content management systems, and broken links plummet in rankings. According to Grehan, all it took was a call to the publisher to fix the link, and after a few days the position was restored.

I guess it works well if you've done your homework as he recommends.

buzz this

From the AdTech Blog: Big Pharma Shifts Bucks and Attention to Direct

Big Pharma Shifts Bucks and Attention to Direct

The FDA approved DTC in 1997. The shift in DTC is an unbelievable opportunity for online. DTC will not go away, there will be a shift to more appropriate communication. The doctor-patient dialogue is essential. Facilitating the dialogue is critical. The current model doesn't work. This panel explored what needs to be done.

Moderator: Joe Hartnett, Hartnett & Associates
Panelists:
Meg Columbia Walsh, Managing Partner CommonHealth Consumer. Pharma and consulting background.
Megan Shawcross, EVP at Xchange. 20 years of making customers the focus.
Bonnie Becker, Director of the pharma category at Yahoo Search Marketing. Was at Pfizer for 5 years, worked in global marketing at Polaroid. At Yahoo is focusing on Pharma to develop best practices.

The FDA approved DTC in 1997. By 2004 $2.5B was spent in DTC. There have been pharma shifts in 2005, many caused by the safety issues with Vioxx and Celebrex. Bill Frist said "drug ads fuel America's skyrocketing drug costs" and "drug companies should wait 2 years before DTC". This caused a change in legislation and changed the market-- DTC is much more restrained now.

We go in and out of paying attention to Pharma as a sector. The shift in DTC is an unbelievable opportunity for online. DTC will not go away, there will be a shift to more appropriate communication. The doctor-patient dialogue is essential. Facilitating the dialogue is critical. The current model doesn't work.

CommonHealth did a study of actual doctor-patient visits for the FDA. The result is engagement based on myth vs. reality. It turns out that DTC was not being spoken about the way the pharma companies expected. It shouldn't be "ask your doctor", it should be "present your story". Not closed-ended, but "how does this migraine affect your life?" DTC does work: it drives patients into the doctor's office-- yet patients still don't ask for medications by name. DTC is not hurting the doctor-patient communication. Yet risk-benefit is not being discussed. Surprisingly, only 3% of observed patients actually "asked their doctors" and over 60% of treatment decisions occurred without the doctor providing additional info. DTC has become just another word for mass advertising. We need a new model. We need consumer-targeted communication and more segmentation.

The shift to direct is a shift to relationship marketing. It provides the opportunity to communicate in a targeted fashion to build a long term relationship. Lives change, so to maintain any sense of relevance, you have to be able to evolve the communication in real time. What's true in a patient's life now will change next year. That's where digital has an advantage. Pharma companies are slow and stuck in the paper-based days, but they're catching up. We need to talk about physical plus holistic (emotional, social) needs, to time communication to key moments of truth vs. call cycles or media flights. There's a need to focus on delivering consistent brand perception and experience always.

Consistency is incredibly important in this process. Most people don't make the connection between the drug, name of product, and the manufacturer. We need to deliver in any channel-- the concept of "everywhere" which was so much discussed at Ad:Tech. DTC can't do that now. We can make the connection between brand, corporate, division, etc. It's about being where the consumer is. Pharma companies need to fit the message into the context of their lives, not push information like advertising. Content delivery is becoming richer. Citizen media is growing (podcasts), search engines make everyone a researcher. Pharma companies need to personalize pull marketing, not just push marketing.

Public and political pressure are accelerating DTC changes. Media consumption has changed-- adults 50+ now spend over 7 hours per week online-- more than with magazines and newspapers. Pharma spending is shifting online, with 35% growth last year. Over 60% of the US population 18+ looked for health info online. 34% of searchers would never take a medication without first looking it up online. 61% of searchers plan to see the doctor after searching. 71% of searchers talk about treatments with doctors. Health consumers are hyper-engaged online, not just looking at health but at everything online. You need to target your audience online via increasingly specific channels: Mass and mass-targeted media, behavioral targeting, and context. Marketers are engaging with sight, sound and motion. Interactive ads are positive because they allow the user to engage your content without leaving the page.

Now comes the digital evolution with social media, "we media" like YouTube, Myspace and flickr. You can get answers from your peers who have direct experience. You can have a diabetes community and social search such as on Yahoo Answers where users provide answers to the community. This happens within minutes, not hours or days.

Trust and permission-based maketing is more important than ever. It took 12 years for pharma to go online, they need to move more quickly to community-based dialog. According to the panelists, pharma had "better show up" in the communities. The boomer audience goes in with full treatment agendas when they visit a doctor, then go back online to validate "Is the drug I was prescribed the right one?" There are great partners in Yahoo and Google, and pharma companies need to use them.

It was a fast-paced session with lots of interesting info. There's a lot of room for what the panelists called "total solution holistic communities" which can be sponsored by the pharma industry. The panelists encouraged the audience to explore these opportunities, as they thought there were some nice economic opportunities there.

It will be interesting to see if, as the big pharma companies actually do engage their audiences more, they'll be able to do the hard work of listening, which is key to relationship building. We'll look forward to an update next year...

buzz this

The Value Of Integrating Search And Display

Commentary
The Value Of Integrating Search And Display
by Yoav Arnstein, Monday, Nov 13, 2006 6:00 AM ET
ONE OF THE MANY CHALLENGES marketers are facing today is identifying ways to successfully integrate search and display, given the increasing dominance of these two categories in online advertising. Earlier this year, JupiterResearch forecast that search would lead online ad spend growth over the next five years, increasing from 41% of all online ad spend to 43% by 2011. Meanwhile, the firm predicted rich media would grow at a 21% compound annual growth rate, with video ad spend increasing at a 27% rate through 2011.

In many cases, search and display are still siloed practices, often reducing the effectiveness of both. In order to maximize each ad dollar while generating maximum brand impact, response and correct attribution of acquisitions, advertisers must fully integrate their digital marketing campaigns across both disciplines. As the use of emerging channels like gaming and mobile proliferate, integration will have ever more increasing importance.

Creative agencies and media planners are increasingly demanding integration of search and display, in order to better serve the brands they represent. To achieve this, many agencies are bringing search expertise in-house, investing in necessary staff and technology. As the scale of online campaigns increase, agencies also need more effective display campaign management.

Another agency demand is for technology that helps optimize online ad spend, especially as budgets increase and the online advertising landscape becomes more complex. More than ever, advertisers need to see maximum impact for each dollar spent online.

Without integration, budgetary decisions and allocations are made up front, even before campaigns are conceived, without any knowledge of performance. By integrating search and display, advertisers can make budgetary decisions during and after planning phases, giving the agency partners more insight into the most effective campaigns, as well as the ability to make changes after initial metrics are reported.

Additionally, display ads are technologically more sophisticated than ever. Wizard-based solutions incorporating advanced capabilities such as full-screen video, and interactive features such as games, texting and music can help advertisers create and manage display ads effectively. The best technology solutions automate ad creation, while requiring minimal post-production work. For example, a flash video used for a rich media banner ad format can be used within a browser game without expensive and timely recoding.

Technology can also help optimize search ad spend. For example, tools can enable agencies to more effectively credit the publishers responsible for a sale. Agencies previously have only been able to give "full credit" to one site for a sale, even if the user had visited multiple sites leading up to a purchase. Now, using the right platform, agencies can assign "partial credit" for the sale, helping the advertiser to plan for a more optimized spend in future campaigns. Thus an agency would be able to assign 30% of the credit for a sale to site A, for example, and 70% to site B.

To summarize, while there may be a general consensus that a conversion can only be attributed to one ad, be it search or display, in fact multiple ads may have contributed to the "birth" process of a conversion. If we agree with that premise, fair distribution of the contributions provided by different media buys should be taken into consideration when planning a campaign and for optimizing a current buy.

The right tools can also help simplify keyword generation with automatic generation of related keywords through data mining.

Other challenges related to search include managing the bidding process and duplicating audiences and conversions. If optimized, all three aspects of search marketing have the potential to return tremendous ROI for the agency.

Providing the benefits of integrated campaigns, especially on a global scale, is a value-added service that can help differentiate truly forward-thinking agencies from those left behind still grappling with traditional ad vehicles.

Yoav Arnstein is general manager of North America for Eyeblaster. He will be speaking at the Search Insider Summit, which will be held Nov. 12-15.

 
buzz this

Study: Doctors Diagnose With Google

Study: Doctors Diagnose With Google
Monday, Nov 13, 2006 6:00 AM ET
IT'S NOT JUST PATIENTS WHO look up their symptoms on Google. Doctors increasingly turn to the search engine to diagnose their patients, according to a new study in the British Medical Journal. "Doctors adept at using the internet use Google to help them diagnose difficult cases," stated the report. "Web based search engines such as Google are becoming the latest tools in clinical medicine, and doctors in training need to become proficient in their use."
buzz this

Friday, November 10, 2006

"Direct Your Dip"

 
Interesting, but really doesn't go the distance. 
 
With just a little more creativity this could have been a hit. 
 
I give it "one star".
buzz this

Niche-Targeted Social Networks Find Audiences

Niche-Targeted Social Networks Find Audiences

Users Flock to Specialized Communities but Don't Abandon MySpace, Others

Source: http://adage.com/digital/article?article_id=112976

NEW YORK (AdAge.com) -- Tanner Stransky, a 23-year-old editorial assistant living in Manhattan, has been a devotee of Facebook since college and has been on MySpace for the past few years as well. But recently he joined a third network, LinkedIn, which aims to be a career-oriented social-networking service for professionals.

More and more, multi-social networkers like him are becoming the norm, as the social-networking space, after being carried the past year and half on the shoulders of sites such as MySpace and Facebook, gets far more diversified. And whether the talk about an exodus from MySpace and Facebook is just a seasonal slowdown or truly indicates a trend, there's a host of niche-targeted social networks just waiting to catch the defectors.

Benjamin Sun is looking for a few former MySpace devotees. Incidentally, his company, Community Connect, has been around longer than MySpace and has been profitable for several years, thanks to a revenue stream that includes advertising and subscription revenues. Soon, he'll launch Glee.com, a social network for the gay, lesbian, bisexual and transgender crowd. It joins his other sites, BlackPlanet, MiGente and AsianAvenue, which aim to attract blacks, Hispanics and Asians, respectively.

'Better to be niche'
"We believe it's better to be niche," he said. "Look at the real-world communities -- they're made up of pockets of people with similar interests." While social networks all look fairly similar now, he said, they're in a primordial stage. "They'll start branching out and super-serving the audience and giving value that you can't find in a general-market site."

At 1Up.com, a content-heavy social site where gamers trade tips, stories, opinions and gossip, the philosophy is that people don't need to choose a single social network -- they can be a part of several. Of its members, 50% also belong to MySpace, 18% to Facebook, 9% to Xanga and 6% to Friendster.

"If our members are blogging about general things, they'll do it on MySpace," said Sam Kennedy, editor in chief of 1Up.com, which is part of Ziff Davis Media Group. "But if it's gaming-related, they reserve that for 1Up because they get better reactions."

Drop in traffic numbers
A drop in traffic numbers has made headlines lately for the larger social-networking sites. According to Nielsen/NetRatings, MySpace's U.S. unique visitors fell 4% to 47.2 million in August, and Facebook's were down 12% to 7.8 million. But a Nielsen/NetRatings analyst wrote off the drop to seasonality and said a similar dip occurred in August last year.

Shawn Gold, senior VP-marketing and content at MySpace, said that there are definitely subcultures emerging within his massive social-networking site. And for users who want efficiency, one social network is certainly easier -- and MySpace is continuing to evolve its tools for self-expression, video, mobile and aggregation.

"The opportunity is MySpace's to lose by not evolving the platform," he said.

Tom Gerace is the CEO of Gather.com, a social network for what's been described as the NPR crowd. The site launched publicly in July and has about 90,000 contributing members today, he said. Already it's attracted marketing partners such as Starbucks, Amazon and Volvo.

"We're not trying to be the next Facebook or MySpace," he said. "They're doing a terrific job for the younger set. We're trying to go after people in the prime of their careers, people with disposable incomes, thought leaders."

buzz this

Dems controlling House not good news for brand name drug makers

Dems controlling House not good news for brand name drug makers
Democrats taking control of the House could mean bad news for brand name drugmakers. According to a Reuters report, Democrats are expected to push for measures that let Medicare negotiate lower drug prices and for a larger government role in healthcare, which may mean federal price setting for drugs in the near future. Reuters reporters quote reactions of department heads from Novartis, Barr, and Teva Pharmaceuticals in their report. Paul Herrling, head of corporate research for Novartis was quoted as saying, "We know what happened last time. I think there will be a second try to change the way that currently the free market works in the U.S." Generic makers Barr and Teva representatives were more positive about the change in House power.
 
buzz this

Thursday, November 09, 2006

Google Revises AdSense Formula

Google Revises AdSense Formula
Thursday, Nov 9, 2006 6:00 AM ET

GOOGLE WILL IN THE NEXT several days start incorporating the quality of the advertisers' landing pages when deciding the placement of their ads across the AdSense network, and has updated the algorithm that calculates landing page quality score. The changes will affect a "very small" portion of advertisers, a Google product marketing manager for ad quality initiatives said on the Inside AdWords blog. Previously, landing page quality was only taken into account when determining the minimum bid for AdWords ads served on Google search results pages.

Shankar Gupta

 
buzz this